COVID-19 Vaccine Inventory Management.    Read More

Contact Us

Why the Pharma Industry Depends on In-Stock and Cold-Chain Compliant Biopharma Products

Pharmaceutical Commerce | September 2019

September 23, 2019

With cold-chain biopharma products totaling more than $360 billion worldwide in 2019, it's essential for the pharma industry to utilize smart refrigeration technology to ensure compliance with the time-sensitive and costly job of storing, handling and managing vaccines and biologics. The pharma industry has long been tasked with the arduous and expensive task of biopharma product storage and inventory. In 2018, the pharma industry spent $15 billion on cold chain logistics. And, a national survey suggested up to 5% of vaccines are wasted, potentially costing up to $31 million due to cold chain lapses, followed by expiration. [full article PDF]